RegMed Daily, Closing Bell, 5/4/12, atrophying share pricing shapes expectation
End of Day, Cause and Effect
EOD Commentary: RegMed stocks added to losses Friday and remained … heavily under pressure … across the board, after a weaker-than-expected government jobs report underscored worries over the strength of the economic recovery. The NASDAQ is on pace for its biggest weekly drop since mid-December. The RegMed universe sell-off got worse as the day went on … volume wasn’t that … heavy again!
Closing Bell: The NASDAQ closed DOWN -67.96 (-2.25%) to 2,956.34. The Dow closed DOWN -168.32 (-1.27%) to 13,038.27.
Who is up … at the close:
- Cryo-Cell (OTC BB: CCEL) +$0.05 <+2.22%> to $2.30;
- Fibrocell (OTC BB: FCSC) +$0.02 <+8.33%> to $0.26;
- NeoStem (Amex: NBS) +$0.007 <+1.91%> to $0.39;
- Opexa (OPXa) +$0.08 <+15.09%> to $0.61;
- ReNeuron (RENE.L) +$0.15 <+4%> to $3.90.
Related Posts
Categories: RegMed Daily Closing Bell
